-
Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-10-02 Francesca Torresan,Federico B Rossi,Ilaria Caputo,Sofia Zanin,Brasilina Caroccia,Andrea Mattarei,Michela Paccagnella,Eva Kohlscheen,Teresa M Seccia,Maurizio Iacobone,Gian-Paolo Rossi
BACKGROUND Primary aldosteronism (PA), the most common curable salt-dependent form of arterial hypertension, features renal K+ loss and enhanced Na+ reabsorption. We investigated whether the electrolyte, water, and TonEBP (tonicity-responsive enhancer binding protein)/NFAT5 (nuclear factor of activated T cells 5) content is altered in the skin of patients with PA and corrected by surgical cure. METHODS
-
Personal Genetic-Hypertension Odyssey From Phenotypes to Genotypes and Targets. Hypertension (IF 6.9) Pub Date : 2024-10-02 Friedrich C Luft
Hypertension requires increased systemic vascular resistance. Thus far, Mendelian hypertension-related genes are related to salt retention, an indirect regulatory effect. With the identification of mutated, overactive, PDE3A (phosphodiesterase 3A), we have uncovered a more direct vasoconstrictive mechanism. The autosomal-dominant syndrome features another specific phenotype, brachydactyly type E. Hypertension
-
Awakening to the Pertinence of Sleep for Hypertension. Hypertension (IF 6.9) Pub Date : 2024-09-30 Tomoyuki Tobushi,John S Floras
-
Maternal Hypertension and Fecundability: A Population-Based Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-09-27 Wenxue Xiong,Lu Han,Xijia Tang,Rui Li,Wen Chen,Xiaohua Liu,Hua Nie,Weibing Qin,Li Ling
BACKGROUND The association of hypertension and blood pressure control with fecundability among women is not yet elucidated. The purpose of this study was to evaluate the hypothesis that maternal preconception hypertension would be associated with reduced fecundability and that blood pressure control could reduce excess risk. METHODS Using the National Free Preconception Checkup Projects in Guangdong
-
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in PA. Hypertension (IF 6.9) Pub Date : 2024-09-25 Yuto Hayama,Emiko Kuribayashi-Okuma,Norihiko Fujii,Fumika Ochiai-Homma,Osamu Yamazaki,Yuya Tsurutani,Tetsuo Nishikawa,Shigeru Shibata
BACKGROUND Aldosterone and the MR (mineralocorticoid receptor) are important therapeutic targets for hypertension and cardiovascular diseases. However, biomarkers of tissue MR signaling are not fully established. Extracellular vesicles released from eukaryotic cells can provide information on tissue signaling. Using samples from patients with primary aldosteronism (PA), we explored the potential of
-
Angiotensin in the Arcuate: Mechanisms Integrating Cardiometabolic Control. Hypertension (IF 6.9) Pub Date : 2024-09-24 Samuel B R Lawton,Valerie A Wagner,Pablo Nakagawa,Jeffrey L Segar,Curt D Sigmund,Lisa L Morselli,Justin L Grobe
BACKGROUND The American Heart Association has identified obesity as a primary impediment to ongoing improvements in cardiovascular diseases, including hypertension. Although drugs, exercise, diets, and surgeries can each cause weight loss, few subjects maintain a reduced weight over the long term. Dysfunctional integrative control (ie, adaptation) of resting metabolic rate (RMR) appears to underlie
-
Intact NOX2 in T Cells Mediates Pregnancy-Induced Renal Damage in Dahl SS Rats. Hypertension (IF 6.9) Pub Date : 2024-09-20 John Henry Dasinger,Justine M Abais-Battad,Samuel D Walton,Emily C Burns-Ray,Mary Cherian-Shaw,Kaitlyn E Baldwin,Daniel J Fehrenbach,David L Mattson
BACKGROUND Hypertensive disorders of pregnancy are associated with increased risk for cardiovascular disease, renal disease, and mortality. While the exact mechanisms remain unclear, T cells and reactive oxygen species have been implicated in its pathogenesis. We utilized Dahl salt-sensitive (SS), SSCD247-/- (Dahl SS CD247 knockout rat; lacking T cells), and SSp67phox-/- (Dahl SS p67phox [NOX2 (NADPH
-
Prevalence and Risk Factors for Secondary Hypertension in Young Adults. Hypertension (IF 6.9) Pub Date : 2024-09-19 Jean-Baptiste de Freminville,Margherita Gardini,Antoine Cremer,Scarlett Camelli,Stephanie Baron,Guillaume Bobrie,Philippe Gosse,Romain Boulestreau,Nicole Gebara,Julien Doublet,Thomas Dussartre,Christine Grataloup,Aurélien Lorthioir,Christine Massien,Anne-Marie Madjalian,Julien Riancho,Gilles Soulat,Nicolas Postel-Vinay,Michel Azizi,Bastien Rance,Laurence Amar
BACKGROUND The prevalence of secondary causes of hypertension in young adults is unknown, and therefore, there is no consensus about the indication of screening of secondary hypertension (2HTN) in this population. The objective was to report the prevalence and the causes of 2HTN in young subjects. METHODS 2090 patients with confirmed hypertension aged 18 to 40 years with full workup for 2HTN screening
-
Clinical Trial Evidence of the Gut Microbial Metabolite Butyrate in Hypertension. Hypertension (IF 6.9) Pub Date : 2024-09-18 Leticia Camargo Tavares,Francine Z Marques
-
Navigating Hypertension in Hypertrophic Obstructive Cardiomyopathy: A Cardiovascular Conundrum. Hypertension (IF 6.9) Pub Date : 2024-09-18 Sean W Dooley,Usman A Tahir,Jennifer L Cluett
-
Association of High Blood Pressure With Post-Traumatic Stress Disorder in Ukrainian Women Refugees. Hypertension (IF 6.9) Pub Date : 2024-09-18 Anna Shalimova,Maria Simona Stoenoiu,Narcis-George Manolache,Wiesław J Cubała,Michel Burnier,Krzysztof Narkiewicz,Alexandre Persu
-
Systolic Blood Pressure, Cardiovascular Health, and Neurocognitive in Adolescents. Hypertension (IF 6.9) Pub Date : 2024-09-18 Stephen R Hooper,Marc B Lande,Joseph T Flynn,Coral D Hanevold,Kevin E Meyers,Joshua Samuels,Richard C Becker,Stephen R Daniels,Bonita E Falkner,Michael A Ferguson,Julie R Ingelfinger,Lisa J Martin,Mark Mitsnefes,Phillip Khoury,Jangdong Seo,Elaine M Urbina
BACKGROUND We studied whether increased systolic blood pressure (SBP), as determined by auscultatory SBP, ambulatory SBP, and the number of cardiovascular health risk indicators, are associated with neurocognition in adolescents. METHODS This cross-sectional study included 365 adolescents (mean age, 15.5 years) from 6 academic medical centers in the United States. The sample was 59.5% male, 52.6% White
-
Dysregulated Mitochondrial Calcium Causes Spiral Artery Remodeling Failure in Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-09-18 Xiyuan Lu,Yifan Wang,Na Geng,Zhiguo Zou,Xueqing Feng,Yuehong Wang,Zhice Xu,Ning Zhang,Jun Pu
BACKGROUND Calcium deficiency in women is strongly linked to an increased risk of developing preeclampsia. Mitochondrial calcium ([Ca2+]m) homeostasis is essential to regulate vascular smooth muscle cell (VSMC) function. However, the role of [Ca2+]m in preeclampsia development remains largely unknown. METHODS To investigate this, human spiral arteries obtained from normotensive and preeclamptic women
-
Optimal Antihypertensive Systolic Blood Pressure: A Systematic Review and Meta-Analysis. Hypertension (IF 6.9) Pub Date : 2024-09-12 Paul K Whelton,Samantha O'Connell,Katherine T Mills,Jiang He
BACKGROUND Systolic blood pressure (SBP) lowering reduces major cardiovascular disease (CVD) and all-cause mortality. However, the optimal target for SBP lowering remains controversial. METHODS We included trials with random allocation to an SBP <130 mm Hg treatment target and CVD as the primary outcome. Data were extracted from each study independently and in duplicate using a standardized protocol
-
Hypertension-Associated Expenditures Among Privately Insured US Adults in 2021. Hypertension (IF 6.9) Pub Date : 2024-09-10 Ashutosh Kumar,Siran He,Lisa M Pollack,Jun Soo Lee,Omoye Imoisili,Yu Wang,Lyudmyla Kompaniyets,Feijun Luo,Sandra L Jackson
BACKGROUND There are no recent estimates for hypertension-associated medical expenditures. This study aims to estimate hypertension-associated incremental medical expenditures among privately insured US adults. METHODS We conducted a retrospective cohort study using IQVIA's Ambulatory Electronic Medical Records-US data set linked with PharMetrics Plus claims data. Among privately insured adults aged
-
Resistant Hypertension and Mortality: An Observational Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-09-09 Alejandro de la Sierra,Luis M Ruilope,Natalie Staplin,Manuel Gorostidi,Ernest Vinyoles,Julián Segura,Pedro Armario,Anna Oliveras,Bryan Williams
BACKGROUND Resistant hypertension is characterized by elevated blood pressure (BP) despite using 3 antihypertensive agents. Ambulatory BP monitoring (ABPM) detects the presence of white-coat resistant hypertension (24-hour BP <130/80 mm Hg). The aim of the study was to evaluate risks of death in resistant hypertension compared with controlled hypertension, as well as in ABPM-confirmed (24-hour BP ≥130
-
Genetic Variance in Heparan Sulfation Is Associated With Salt Sensitivity. Hypertension (IF 6.9) Pub Date : 2024-09-09 Jetta J Oppelaar,Bart Ferwerda,Mohamed A Romman,Ghazalah N Sahebdin,Aeilko H Zwinderman,Henrike Galenkamp,S Matthijs Boekholdt,Bert-Jan H van den Born,Rik H G Olde Engberink,Liffert Vogt
BACKGROUND High heritability of salt sensitivity suggests an essential role for genetics in the relationship between sodium intake and blood pressure (BP). The role of glycosaminoglycan genes, which are crucial for salinity tolerance, remains to be elucidated. METHODS Interactions between 54 126 variants in 130 glycosaminoglycan genes and daily sodium excretion on BP were explored in 20 420 EPIC-Norfolk
-
Global Blood Pressure Screening During and After Pregnancy: May Measurement Month 2019. Hypertension (IF 6.9) Pub Date : 2024-09-09 Liza Bowen,Richard Stevens,Aletta E Schutte,Thomas Beaney,Neil Poulter,Richard J McManus,Lucy C Chappell
BACKGROUND Hypertensive disorders of pregnancy are associated with high maternal and fetal morbidity and mortality. There are limited global data on the characteristics of women during and after pregnancy hypertension. METHODS May Measurement Month is a global campaign to raise awareness of the importance of blood pressure. Adults (≥18 years) recruited through opportunistic sampling during May 2019
-
Blood Pressure-Lowering Medications, Sodium Reduction, and Blood Pressure. Hypertension (IF 6.9) Pub Date : 2024-09-05 Jing Song,Liangkai Chen,Hui Xiong,Yuan Ma,Sonia Pombo-Rodrigues,Graham A MacGregor,Feng J He
BACKGROUND Both blood pressure-lowering medication and sodium reduction are effective in hypertension control, but whether blood pressure-lowering medication modifies the effect of sodium reduction is unclear. This study aims to evaluate the dose-response effect of sodium intake reduction on blood pressure in treated hypertensive individuals and the impact of different classes of blood pressure-lowering
-
Arm Size Coverage of Popular Over-the-Counter Blood Pressure Devices and Implications in US Adults. Hypertension (IF 6.9) Pub Date : 2024-09-05 Eileen Kaur,Asma Rayani,Tammy M Brady,Kunihiro Matsushita
-
Autonomic Dysregulation in Pulmonary Hypertension: Role of Physical Exercise. Hypertension (IF 6.9) Pub Date : 2024-09-05 Leôncio Lopes Soares,Alexandre Martins Oliveira Portes,Sebastião Felipe Ferreira Costa,Luciano Bernardes Leite,Antônio José Natali
Pulmonary hypertension (PH) is a rare and severe condition characterized by increased pressure in the pulmonary circulation, often resulting in right ventricular failure and death. The autonomic nervous system (ANS) plays a crucial role in the cardiovascular and pulmonary controls. Dysfunction of ANS has been implicated in the pathogenesis of cardiopulmonary diseases. Conversely, dysfunctions in ANS
-
Prevalence of Hyperkalemia and Familial Hyperkalemic Hypertension in 5100 Patients Referred to a Tertiary Hypertension Unit. Hypertension (IF 6.9) Pub Date : 2024-09-04 Martina Tetti,Jacopo Burrello,Marguerite Hureaux,Clarisse Billon,Eric Clauser,Franco Veglio,Franco Rabbia,Barbara Pasini,Annalisa Crisetti,Xavier Jeunemaitre,Paolo Mulatero,Silvia Monticone
BACKGROUND Hyperkalemia is a frequent electrolyte alteration whose prevalence varies widely, depending on the adopted cutoff, the setting (inpatients versus outpatients), and the characteristics of the study population. Familial hyperkalemic hypertension (FHH) is a rare cause of hypertension, hyperkalemia, and hyperchloremic metabolic acidosis. METHODS In this retrospective observational study, we
-
Achieving Equity in Hypertension: A Review of Current Efforts by the American Heart Association. Hypertension (IF 6.9) Pub Date : 2024-09-04 Shakia T Hardy,Valy Fontil,Glenn H Dillon,Daichi Shimbo
The purpose of this article is to summarize disparities in blood pressure (BP) by race in the United States, discuss evidence-based strategies to increase equity in BP, review recent American Heart Association BP equity initiatives, and highlight missed opportunities for achieving equity in hypertension. Over 122 million American adults have hypertension, with the highest prevalence among Black Americans
-
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021. Hypertension (IF 6.9) Pub Date : 2024-09-04 Joshua A Jacobs,Anthony Rodgers,Brandon K Bellows,Inmaculada Hernandez,Nelson Wang,Catherine G Derington,Jordan B King,Alexander R Zheutlin,Paul K Whelton,Brent M Egan,William C Cushman,Adam P Bress
BACKGROUND Antihypertensive medication use patterns have likely been influenced by changing costs and accessibility over the past 3 decades. This study examines the relationships between patent exclusivity loss, medication costs, and national health policies on antihypertensive medication use. METHODS Using 1996 to 2021 Medical Expenditure Panel Survey data of US adults with hypertension taking at
-
Sex Differences in Hypertension and Its Management Throughout Life. Hypertension (IF 6.9) Pub Date : 2024-09-04 Wan-Jin Yeo,Rahul Abraham,Aditya L Surapaneni,Pascal Schlosser,Shoshana Ballew,Bige Ozkan,Carina M Flaherty,Bing Yu,Joseph V Bonventre,Chirag Parikh,Paul L Kimmel,Ramachandran S Vasan,Josef Coresh,Morgan E Grams
BACKGROUND The prevalence of hypertension and uncontrolled hypertension may differ by age and sex. METHODS We included participants in the Atherosclerosis Risk in Communities study at seven study visits over 33 years (visit 1: 15 636 participants; mean age, 54 years; 55% women), estimating sex differences in prevalence of hypertension (systolic blood pressure ≥130 mm Hg; diastolic blood pressure ≥80
-
Association of Snoring and Daytime Sleepiness With Subsequent Incident Hypertension: A Population-Based Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-09-04 Pauline Balagny,Emmanuelle Vidal-Petiot,Sofiane Kab,Justine Frija,Philippe Gabriel Steg,Marcel Goldberg,Marie Zins,Marie-Pia d'Ortho,Emmanuel Wiernik
BACKGROUND There is a strong association between obstructive sleep apnea and hypertension, but the effects of obstructive sleep apnea symptoms on the risk of incident hypertension are not well documented. The aim of this prospective study was to examine whether snoring and sleepiness are associated with incident hypertension. METHODS Data from the French population-based CONSTANCES cohort were analyzed
-
GPER Stimulation Attenuates Cardiac Dysfunction in a Rat Model of Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-09-03 Allan Kardec Nogueira de Alencar,Kenneth F Swan,Smruti Mahapatra,Sarah H Lindsey,Gabriella C Pridjian,Carolyn L Bayer
BACKGROUND Preeclampsia poses a substantial clinical challenge, characterized by maternal hypertension, cardiac dysfunction, and persistent cardiovascular risks for both the mother and offspring. Despite the known roles of the estrogen receptor (GPER [G protein-coupled estrogen receptor]) in placental development, its impact on cardiovascular aspects within a preeclampsia animal model remains unexplored
-
Hypertension and Left Ventricular Strain in Pediatric Chronic Kidney Disease. Hypertension (IF 6.9) Pub Date : 2024-08-28 Alexander J Kula,Yunwen Xu,Garick D Hill,Susan L Furth,Bradley A Warady,Derek K Ng,Jeese Seegmiller,Mark Mitsnefes,
BACKGROUND Left ventricular global longitudinal strain (LV GLS) on echocardiography is a sensitive yet clinically significant marker of myocardial dysfunction. Reduced LV GLS is prevalent in adults with chronic kidney disease and hypertension and is associated with adverse cardiovascular outcomes. It may be a biomarker of chronic kidney disease-associated myocardial dysfunction in children, but data
-
Collecting Duct Pro(Renin) Receptor Contributes to Unilateral Ureteral Obstruction-Induced Kidney Injury via Activation of the Intrarenal RAS. Hypertension (IF 6.9) Pub Date : 2024-08-22 Renfei Luo,Kevin T Yang,Fei Wang,Huaqing Zheng,Tianxin Yang
BACKGROUND Although the concept of the intrarenal renin-angiotensin system (RAS) in renal disease is well-described in the literature, the precise pathogenic role and mechanism of this local system have not been directly assessed in the absence of confounding influence from the systemic RAS. The present study used novel mouse models of collecting duct (CD)-specific deletion of (pro)renin receptor (PRR)
-
Hypertensive Disorders of Pregnancy and Brain Health in Midlife: The CARDIA Study. Hypertension (IF 6.9) Pub Date : 2024-08-20 Xiaqing Jiang,Pamela J Schreiner,Erica P Gunderson,Kristine Yaffe
BACKGROUND To understand the role of hypertensive disorders of pregnancy (HDP), including preeclampsia and gestational hypertension (GH), in brain health earlier in life, we investigated the association of HDP with midlife cognition and brain health. METHODS We studied a prospective cohort of women, baseline age 18 to 30 years, who were assessed at study years 25 and 30 with a cognitive battery and
-
Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension. Hypertension (IF 6.9) Pub Date : 2024-08-20 Danchen Wu,Ross D Jansen-van Vuuren,Asish Dasgupta,Ruaa Al-Qazazi,Kuang-Hueih Chen,Ashley Y Martin,Jeffrey D Mewburn,Elahe Alizadeh,Patricia D A Lima,Oliver Jones,Pierce Colpman,Rachel E T Bentley,M Martin VandenBroek,Nolan M Breault,Isaac M Emon,V Siddartha Yerramilli,Luka Jedlovčnik,Yuan Yuan Zhao,Michael Wells,Gopinath Sutendra,Mark L Ormiston,Stephen L Archer
BACKGROUND Drp1 (dynamin-related protein 1), a large GTPase, mediates the increased mitochondrial fission, which contributes to hyperproliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension (PAH). We developed a potent Drp1 GTPase inhibitor, Drpitor1a, but its specificity, pharmacokinetics, and efficacy in PAH are unknown. METHODS Drpitor1a's ability to inhibit recombinant
-
Predictive and Diagnostic Value of the Angiogenic Proteins in Patients With Chronic Kidney Disease. Hypertension (IF 6.9) Pub Date : 2024-08-20 Nir Melamed,John Kingdom,Lei Fu,Paul M Yip,Isabel Arruda-Caycho,Dini Hui,Michelle Hladunewich
BACKGROUND Our objective was to investigate the predictive and diagnostic accuracy of the angiogenic proteins sFlt-1 (soluble fms-like tyrosine kinase-1) and PlGF (placental growth factor) for preterm preeclampsia and explore the relationship between renal function and these proteins. METHODS We completed a blinded prospective, longitudinal, observational study of patients with chronic kidney disease
-
George L. Bakris, MD (1952 to 2024). Hypertension (IF 6.9) Pub Date : 2024-08-14 Rajiv Agarwal,Matthew R Weir
-
Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension. Hypertension (IF 6.9) Pub Date : 2024-08-13 Lisa A Gottlieb,Felix Mahfoud,Stavros Stavrakis,Thomas Jespersen,Dominik Linz
More than 1.5 billion people worldwide have arterial hypertension. Hypertension increases the risks of death and cardiovascular disease, such as atrial fibrillation and heart failure. The autonomic nervous system plays an essential role in hypertension development and disease progression. While lifestyle factors, such as obesity and obstructive sleep apnea, predispose to hypertension by increasing
-
Update on Low-Renin Hypertension: Current Understanding and Future Direction. Hypertension (IF 6.9) Pub Date : 2024-08-13 Sonali S Shah,Peter J Fuller,Morag J Young,Jun Yang
Low-renin hypertension is common and affects 1 in 4 people with hypertension. Understanding the different causes and management of low-renin hypertension is becoming increasingly relevant as renin measurements are more widely ordered in clinical practice. Importantly, many people with low-renin hypertension do not fit traditional definitions of known causes, and the approach to management of these
-
Home Blood Pressure Variability Risk Prediction Score for Cardiovascular Disease Using Data From the J-HOP Study. Hypertension (IF 6.9) Pub Date : 2024-08-13 Kazuomi Kario,Hiroshi Kanegae,Yukie Okawara,Naoko Tomitani,Satoshi Hoshide
BACKGROUND Home blood pressure (BP) is more closely associated with cardiovascular event risk than office BP, but cardiovascular risk prediction based on home BP variability is lacking. This study developed a simple cardiovascular event prediction score, including home BP variability data, from the J-HOP study (Japan Morning Surge-Home Blood Pressure). METHODS The J-HOP study extended follow-up from
-
Blood-Brain Barrier Integrity Decreases With Higher Blood Pressure: A 7T DCE-MRI Study. Hypertension (IF 6.9) Pub Date : 2024-08-13 Marieke van den Kerkhof,Joost J A de Jong,Paulien H M Voorter,Alida A Postma,Abraham A Kroon,Robert J van Oostenbrugge,Jacobus F A Jansen,Walter H Backes
BACKGROUND Blood-brain barrier (BBB) integrity is presumed to be impaired in hypertension, resulting from cerebral endothelial dysfunction. Hypertension precedes various cerebrovascular diseases, such as cerebral small vessel disease, and is a risk factor for developing neurodegenerative diseases for which BBB disruption is a preceding pathophysiological process. In this cross-sectional study, we investigated
-
Binge Alcohol Consumption Elevates Sympathetic Transduction to Blood Pressure: A Randomized Controlled Trial. Hypertension (IF 6.9) Pub Date : 2024-08-09 Jeremy A Bigalke,Ian M Greenlund,Tatiana X Solis-Montenegro,John J Durocher,Michael J Joyner,Jason R Carter
BACKGROUND Alcohol consumption is associated with cardiovascular disease, and the sympathetic nervous system is a suspected mediator. The present study investigated sympathetic transduction of muscle sympathetic nerve activity to blood pressure at rest and in response to cold pressor test following evening binge alcohol or fluid control, with the hypothesis that sympathetic transduction would be elevated
-
Age-Related Blood Pressure Gradients Are Associated With Blood Pressure Control and Global Population Outcomes. Hypertension (IF 6.9) Pub Date : 2024-08-07 Janis M Nolde,Thomas Beaney,Revathy Carnagarin,George S Stergiou,Neil R Poulter,Aletta E Schutte,Markus P Schlaich
BACKGROUND The strong relationship between blood pressure (BP) and age is well known. Limited evidence suggests that a steeper age-BP slope may be associated with an increased risk of adverse outcomes. The May Measurement Month campaign enables an investigation of geographic, socioeconomic, and sex differences in age-related BP gradients and their association with public-health outcomes. METHODS Cross-sectional
-
Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine. Hypertension (IF 6.9) Pub Date : 2024-08-07 L E Okamoto,V Urechie,S Rigo,J J Abner,M Giesecke,J A S Muldowney,R Furlan,C A Shibao,J K Shirey-Rice,J M Pulley,A Diedrich,Italo Biaggioni
BACKGROUND A subset of patients with postural tachycardia syndrome (POTS) are thought to have a primary hyperadrenergic cause. We assessed clinical biomarkers to identify those that would benefit from sympatholytic therapy. METHODS We measured sympathetic function (supine muscle sympathetic nerve activity, upright plasma norepinephrine, and blood pressure responses to the Valsalva maneuver) in 28 patients
-
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension (IF 6.9) Pub Date : 2024-08-05 Jennifer L Cluett,Olivia Blazek,Angela L Brown,Cara East,Keith C Ferdinand,Naomi D L Fisher,Cassandra D Ford,Karen A Griffin,Carlos I Mena-Hurtado,Harini Sarathy,Wanpen Vongpatanasin,Raymond R Townsend,
Hypertension is a leading risk factor for cardiovascular morbidity and mortality. Despite the widespread availability of both pharmacological and lifestyle therapeutic options, blood pressure control rates across the globe are worsening. In fact, only 23% of individuals with high blood pressure in the United States achieve treatment goals. In 2023, the US Food and Drug Administration approved renal
-
Cardiac Effects of Renin-Angiotensin System Inhibitors in Nonproteinuric CKD. Hypertension (IF 6.9) Pub Date : 2024-08-01 Rachel S Shulman,Wei Yang,Debbie L Cohen,Peter P Reese,Jordana B Cohen,
BACKGROUND In contrast to proteinuric chronic kidney disease (CKD), the relative cardioprotective benefits of antihypertensive medications in nonproteinuric CKD are unknown. We examined long-term cardiovascular outcomes and mortality in patients with nonproteinuric CKD treated with renin-angiotensin system inhibitors (RASIs) versus other antihypertensive medications. METHODS Among participants of the
-
Epigenetic Clock at Birth and Childhood Blood Pressure Trajectory: A Prospective Birth Cohort Study. Hypertension (IF 6.9) Pub Date : 2024-08-01 Jie Hu,Anat Yaskolka Meir,Xiumei Hong,Guoying Wang,Frank B Hu,Xiaobin Wang,Liming Liang
BACKGROUND The impact of methylation gestational age (GAmAge; a biomarker of fetal maturity) at birth on childhood blood pressure (BP) trajectories is unknown. METHODS This cohort study included 500 boys and 440 girls with data on cord blood DNA methylation and BP at 3 to 15 years of age. Systolic BP (SBP) and diastolic BP percentiles were calculated based on clinical guidelines. Time-series K-means
-
Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs. Hypertension (IF 6.9) Pub Date : 2024-07-31 Georgiana Constantinescu,Sven Gruber,Sybille Fuld,Mirko Peitzsch,Manuel Schulze,Hanna Remde,Lydia Kürzinger,Jun Yang,Tina Yen,Tracy Ann Williams,Lisa Müller,Martin Reincke,Jacques W M Lenders,Felix Beuschlein,Christina Pamporaki,Graeme F Eisenhofer
BACKGROUND Diagnosis of primary aldosteronism (PA) is complicated by the need to withdraw antihypertensive medications that interfere with test results, particularly renin. This study examined whether machine learning-based steroid-probability scores offer a renin measurement-independent approach for testing less prone to interference than the aldosterone-to-renin ratio (ARR). METHODS This prospective
-
UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide. Hypertension (IF 6.9) Pub Date : 2024-07-30 Linsay McCallum,Stefanie Lip,Alex McConnachie,Katriona Brooksbank,Iain M MacIntyre,Alexander Doney,Andrea Llano,Alisha Aman,Thomas M Caparrotta,Gareth Ingram,Isla S Mackenzie,Anna F Dominiczak,Thomas M MacDonald,David J Webb,Sandosh Padmanabhan
BACKGROUND UMOD (uromodulin) has been linked to hypertension through potential activation of Na+-K+-2Cl- cotransporter (NKCC2), a target of loop diuretics. We posited that hypertensive patients carrying the rs13333226-AA UMOD genotype would demonstrate greater blood pressure responses to loop diuretics, potentially mediated by this UMOD/NKCC2 interaction. METHODS This prospective, multicenter, genotype-blinded
-
Lipoproteins and Exosomes as Novel Carriers of Soluble Fms-Like Tyrosine Kinase-1 and Placental Growth Factor During Pregnancy. Hypertension (IF 6.9) Pub Date : 2024-07-30 Lunbo Tan,Martijn H van Heugten,Ans C M Kluivers,Leonie van Vark-van der Zee,Monique T Mulder,Xifeng Lu,A H Jan Danser,Koen Verdonk
-
Cardiovascular Health Starts in the Womb. Hypertension (IF 6.9) Pub Date : 2024-07-29 Bonita Falkner,Barbara T Alexander,Anne-Monique Nuyt,Andrew M South,Julie Ingelfinger
Hypertension has largely been viewed as a disorder of adulthood. Historically, blood pressure (BP) was not routinely measured in children because hypertension was considered uncommon in childhood. It was not until the 1970s that it was apparent that in childhood BP levels were normally lower compared with those in adults, were related to age and growth, and that abnormal BP in children needed different
-
Premorbid Blood Pressure Control Modifies Risk of DWI Lesions With Acute Blood Pressure Reduction in Intracerebral Hemorrhage. Hypertension (IF 6.9) Pub Date : 2024-07-29 Mohamed Ridha,Yousef Hannawi,Santosh Murthy,Fernanda Carvalho Poyraz,Aditya Kumar,Soojin Park,David Roh,Padmini Sekar,Daniel Woo,James Burke
BACKGROUND Hypoperfusion due to blood pressure (BP) reduction is a potential mechanism of cerebral ischemia after intracerebral hemorrhage. However, prior evaluations of the relationship between BP reduction and ischemia have been conflicting. Untreated chronic hypertension is common in intracerebral hemorrhage and alters cerebral autoregulation. We hypothesized that the risk of diffusion-weighted
-
Clinical Management of Primary Aldosteronism: An Update. Hypertension (IF 6.9) Pub Date : 2024-07-24 Gian Paolo Rossi,Federico Bernardo Rossi,Chiara Guarnieri,Giacomo Rossitto,Teresa M Seccia
Despite carrying an excess risk of cardiovascular events, primary aldosteronism (PA) is a commonly overlooked secondary form of arterial hypertension. An increased awareness of its high prevalence and broader screening strategies are urgently needed to improve its detection rate and allow early diagnosis and targeted treatment. For patients with unilateral PA, these measures can correct hyperaldosteronism
-
Novel Role of 5-Methyl-(6S)-Tetrahydrofolate in Mediating Endothelial Cell Tetrahydrobiopterin in Pregnancy and Implications for Gestational Hypertension. Hypertension (IF 6.9) Pub Date : 2024-07-23 Yasmin Dickinson,Ruth Boehni,Rima Obeid,Jean-Pierre Knapp,Rudolf Moser,Adam J Lewandowski,Gillian Douglas,Paul Leeson,Keith M Channon,Surawee Chuaiphichai
BACKGROUND Folate intake during pregnancy is essential for fetal development and maternal health. However, the specific effects of folic acid (FA) and 5-methyl-(6S)-tetrahydrofolate (5-MTHF) on the prevention and treatment of hypertensive disorders of pregnancy remain unclear. We investigated whether FA and 5-MTHF have different effects on endothelial cell tetrahydrobiopterin (BH4) metabolism in pregnancy
-
Effects and Thresholds of Young to Midlife Vascular Risks on Brain Health. Hypertension (IF 6.9) Pub Date : 2024-07-23 Matthew B Maas,Simin Mahinrad,Sanaz Sedaghat,Kristine Yaffe,Lenore J Launer,R Nick Bryan,Stephen Sidney,Philip B Gorelick,Donald M Lloyd-Jones,Farzaneh A Sorond
BACKGROUND Vascular risk factors, particularly hypertension, are important contributors to accelerated brain aging. We sought to quantify vascular risk factor risks over adulthood and assess the empirical evidence for risk thresholds. METHODS We used SBP (systolic blood pressure) and diastolic blood pressure, total cholesterol, fasting blood glucose, and body mass index measurements collected from
-
Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism. Hypertension (IF 6.9) Pub Date : 2024-07-23 Marco Marcelli,Caixia Bi,John W Funder,Michael J McPhaul
BACKGROUND In many practices, the screening for primary aldosteronism relies on a single-blood draw for plasma aldosterone concentration (PAC) and plasma renin activity (PRA) to establish an aldosterone-to-renin ratio (ARR). ARR levels vary between expert centers and repeated assays in the same individual, emphasizing the potential variability of this screening approach. A suppressed PRA to <1 ng/mL
-
Coronary and Systemic Vasodilator Responsiveness of Patients Receiving Conventional Intermittent or Nocturnal Hemodialysis. Hypertension (IF 6.9) Pub Date : 2024-07-23 Christopher B Overgaard,William Chan,Saqib Chowdhary,Rebecca L Zur,Rodrigo Wainstein,Vladimír Džavík,Christopher T Chan,John S Floras
BACKGROUND Nocturnal hemodialysis (nHD) restores the attenuated brachial artery vasodilator responsiveness of patients receiving conventional intermittent hemodialysis (iHD). Its impact on coronary vasodilatation is unknown. METHODS We evaluated 25 patients on hemodialysis who fulfilled transplant criteria: 15 on iHD (4-hour sessions, 3 d/wk) and 10 on nHD (≈40 h/wk over 8-10-hour sessions) plus 6
-
Effects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial. Hypertension (IF 6.9) Pub Date : 2024-07-22 Barbara J H Verhaar,Madelief Wijdeveld,Koen Wortelboer,Elena Rampanelli,Johannes H M Levels,Didier Collard,Marianne Cammenga,Vanasa Nageswaran,Arash Haghikia,Ulf Landmesser,Xinmin S Li,Joseph A DiDonato,Stanley L Hazen,Ingrid M Garrelds,A H Jan Danser,Bert-Jan H van den Born,Max Nieuwdorp,Majon Muller
BACKGROUND The microbiota-derived short chain fatty acid butyrate has been shown to lower blood pressure (BP) in rodent studies. Nonetheless, the net effect of butyrate on hypertension in humans remains uncovered. In this study, for the first time, we aimed to determine the effect of oral butyrate on BP in patients with hypertension. METHODS We performed a double-blind randomized placebo-controlled
-
Sham-Controlled Randomized Pilot Trial on Baroreflex Activation Therapy in Resistant Hypertension. Hypertension (IF 6.9) Pub Date : 2024-07-17 Johan R Simonsen,Leena Vikatmaa,Pirkka Vikatmaa,Mika Laine,Hanna Granroth-Wilding,Per-Henrik Groop,Ilkka Tikkanen,Daniel Gordin
-
Correction to: Eicosanoid-Regulated Myeloid ENaC and Isolevuglandin Formation in Human Salt-Sensitive Hypertension. Hypertension (IF 6.9) Pub Date : 2024-07-17
-
Potential United States Population Impact of the 2023 PREVENT Risk Calculator on Hypertension Management. Hypertension (IF 6.9) Pub Date : 2024-07-17 Joseph Heaton,Steven Imburgio,Anton Mararenko,Ndausung Udongwo,Abbas Alshami,Matthew Schoenfeld,Renato Apolito,Jeffrey Selan,Brett Sealove,Jesus Almendral
-
Impact of Hypertension Duration on the Cardiovascular Benefit of Intensive Blood Pressure Control. Hypertension (IF 6.9) Pub Date : 2024-07-17 Qianhui Ling,Xilan Dong,Jingjing Bai,Yue Deng,Qirui Song,Jun Cai
BACKGROUND The optimal timing for initiating intensive systolic blood pressure (SBP) treatment remains unclear. While longer hypertension duration is positively associated with increased cardiovascular disease risk, it is unknown whether patients with prolonged hypertension can derive similar benefits from intensive SBP treatment. METHODS From the STEP trial (Strategy of Blood Pressure Intervention
-
Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia. Hypertension (IF 6.9) Pub Date : 2024-07-17 Bianca R Fato,Natasha de Alwis,Sally Beard,Natalie K Binder,Natasha Pritchard,Tu'uhevaha J Kaitu'u-Lino,Kristen J Bubb,Natalie J Hannan
BACKGROUND Preeclampsia is a serious condition of pregnancy, complicated by aberrant maternal vascular dysfunction. CNP (C-type natriuretic peptide) contributes to vascular homeostasis, acting through NPR-B (natriuretic peptide receptor-B) and NPR-C (natriuretic peptide receptor-C). CNP mitigates vascular dysfunction of arteries in nonpregnant cohorts; this study investigates whether CNP can dilate
-
Transforming Hypertension Diagnosis and Management in The Era of Artificial Intelligence: A 2023 National Heart, Lung, and Blood Institute (NHLBI) Workshop Report. Hypertension (IF 6.9) Pub Date : 2024-07-16 Daichi Shimbo,Rashmee U Shah,Marwah Abdalla,Ritu Agarwal,Faraz S Ahmad,Gabriel Anaya,Zachi I Attia,Sheana Bull,Alexander R Chang,Yvonne Commodore-Mensah,Keith Ferdinand,Kensaku Kawamoto,Rohan Khera,Jane Leopold,James Luo,Sonya Makhni,Bobak J Mortazavi,Young S Oh,Lucia C Savage,Erica S Spatz,George Stergiou,Mintu P Turakhia,Paul K Whelton,Clyde W Yancy,Erin Iturriaga
Hypertension is among the most important risk factors for cardiovascular disease, chronic kidney disease, and dementia. The artificial intelligence (AI) field is advancing quickly, and there has been little discussion on how AI could be leveraged for improving the diagnosis and management of hypertension. AI technologies, including machine learning tools, could alter the way we diagnose and manage